Merck creates separate oncology arm ahead of Keytruda patent loss
Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across its
Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across its
Royal Bank of Canada stock has been in an unstoppable bull run in the past few years and is now hovering at its
Millions of people on GLP-1 weight-loss drugs know the weekly routine by heart: a new injector pen, a new box, another reminder to
US equities were little changed on Monday after President Donald Trump announced an increase in global tariffs to 15%, following a Supreme Court
Almirall, a pharmaceutical firm based in Spain, ended 2025 with a net profit of €46.2 million, which was 357% more than its 2024
Vanda Pharmaceuticals (NASDAQ: VNDA) opened some 45% higher today after the biotech firm said it has received the FDA’s approval for its treatment
Nvidia stock (NASDAQ: NVDA) ticked higher on Monday as Wall Street headed into the chipmaker’s Feb. 25 earnings report with expectations already sky-high.
South Korea’s stablecoin framework is facing renewed scrutiny as the country’s central bank urges lawmakers to keep control of won-pegged digital tokens within
Finland’s IQM is positioning itself at the centre of Europe’s quantum technology ambitions as it prepares to enter public markets in the US.
Blue Owl stock price has crashed in the past few months, turning one of the most blue-chip financial giants into a fallen angel.